October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

It looks like it is going to be another banner year for USCAP registrations to date. Spend some time on the exhibit floor and see the latest and greatest in 2016! PathXL will be attending USCAP 2016 to showcase their entire digital...

Congratulations to Dr. Hamilton and the team at PathXL on this patent.  Look for more patents to be granted to PathXL in the future.  There is a perfect storm brewing right now in digital pathology -- goals for precision medicine, image...

Last Friday I published a post on a recent ad campaign put out by the American Osteopathic Association (AOA) that many felt in response was "tone deaf", "misguided", "inappropriate" and "awkward" with a call from many for the AOA to pull the...

"The Pathologist" Magazine has named Prof. Bosman #6 on The Power List for 2015. Professor Fred T. Bosman obtained both an M.D. and a Ph.D. from the University of Leiden, The Netherlands. This is also where he also trained as a pathologist....

According to its website, the American Osteopathic Association (AOA), it has launched a new campaign entitled "Brand Awareness Campaign" which it claims is "taking osteopathic medicine to a wider audience with a new brand awareness campaign,...

OR

platinum partners

gold partners

Silver Partners

Media Partners